The micro-elimination of HCV is the complete reduction of HCV infection to zero in targeted populations (e.g. PLHIV, prisoners, haemophiliacs), settings (e.g. hospitals), or limited geographic areas (e.g. Iceland). Substantial steps toward micro-elimination have already been undertaken in most high-income countries, typically focused on those with advanced liver disease. Ireland, for example, has effectively eradicated HCV in its hemophilia-patient population. In some countries, e.g. Australia, the Republic of Georgia, Iceland, Portugal and Spain, broader elimination efforts are well underway. To raise awareness on such accomplishments and boost the conversation surrounding the challenges to expanding HCV micro-elimination, the EILF is hosting a first closed door meeting (invitation only) during The International Liver Congress™ 2017 in view of working on the development of an action plan.
To learn more, contact us.